tykhr
sign in
free sign up
Terns Pharmaceuticals Inc
Biotechnology
Healthcare
TERN
77.82 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
3.79
52 week high
10.04
high
4.08
52 week low
2.00
low
3.66
growth
-54.69 %
previous Close
3.79
P/E ratio
market cap
490 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-21.95 M
3.48 %
eps
0.00 %
9.68 %
eps surprise
12.50 %
net profit margin
-2194500000.00 %
0.00 %
operating incoming
-24.94 M
2.34 %
net change in cash
179 M
576.74 %
cash on hand
270 M
195.24 %
cost of revenue
0.00 %
top